5518 J. Agric. Food Chem., Vol. 58, No. 9, 2010
Wang et al.
Table 2. 1H NMR Spectral Data of Compounds 6 and 7
compound
δ (CDCl3, 400 MHz)
6a
6b
6c
10.34 (s, 1H, CH), 6.46-8.29 (m, 8H, Ar-H), 5.28 (s, 2H, CH2), 3.87 (t, J = 4.8 Hz, 4H, piperazine-H), 2.90 (t, J = 4.8 Hz, 4H, piperazine-H)
10.70 (s, 1H, CH), 6.45-8.29 (m, 7H, Ar-H), 5.28 (s, 2H, CH2), 3.86 (t, J = 4.8 Hz, 4H, piperazine-H), 2.90 (t, J = 4.8 Hz, 4H, piperazine-H)
10.07 (s, 1H, CH), 8.28 (d, J = 4.8 Hz, 2H, pyrimidine-H), 7.82 (d, J = 8.8 Hz, 2H, Ph-H), 6.98 (d, J = 8.8 Hz, 2H, Ph-H), 6.47 (t, J = 4.8 Hz, 1H, pyrimidine-H), 5.28
(s, 2H, CH2), 3.88 (s, 3H, OCH3), 3.86 (t, J = 4.8 Hz, 4H, piperazine-H), 2.90 (t, J = 4.8 Hz, 4H, piperazine-H)
10.35 (s, 1H, CH), 8.14 (d, J = 4.4 Hz, 1H, pyrimidine-H), 7.47-7.88 (m, 5H, Ph-H), 6.35 (d, J = 4.4 Hz, 1H, pyrimidine-H), 5.29 (s, 2H, CH2), 3.87 (t, J = 4.0 Hz, 4H,
piperazine-H), 2.89 (t, J = 4.0 Hz, 4H, piperazine-H), 2.31 (s, 3H, CH3)
6d
6e
6f
10.70 (s, 1H, CH), 8.13 (d, J = 4.4 Hz, 1H, pyrimidine-H), 7.15-8.09 (m, 4H, Ph-H), 6.35 (d, J = 4.4 Hz, 1H, pyrimidine-H), 5.28 (s, 2H, CH2), 3.88 (bs, 4H, piperazine-
H), 2.89 (bs, 4H, piperazine-H), 2.31 (s, 3H, CH3)
10.08 (s, 1H, CH), 8.13 (d, J = 4.8 Hz, 1H, pyrimidine-H), 7.82 (d, J = 8.0 Hz, 2H, Ph-H), 6.99 (d, J = 8.0 Hz, 2H, Ph-H), 6.35 (d, J = 4.8 Hz, 1H, pyrimidine-H), 5.28
(s, 2H, CH2), 3.88 (bs, 7H, CH3O þ piperazine-H), 2.89 (bs, 4H, piperazine-H), 2.31 (s, 3H, CH3)
6g
10.11 (s, 1H, CH), 8.13 (d, J = 4.8 Hz, 1H, pyrimidine-H), 7.63 (s, 1H, Ph-H), 7.60 (d, J = 8.0 Hz, 1H, Ph-H), 7.24 (d, J = 8.0 Hz, 1H, Ph-H), 6.35 (d, J = 4.8 Hz,
1H, pyrimidine-H), 5.28 (s, 2H, CH2), 3.87 (bs, 4H, piperazine-H), 2.89 (bs, 4H, piperazine-H), 2.33 (s, 3H, Ph-CH3), 2.32 (s, 3H, Ph-CH3), 2.31 (s, 3H,
pyrimidine-CH3)
6h
6i
10.44 (s, 1H, CH), 8.13 (d, J = 4.8 Hz, 1H, pyrimidine-H), 7.80 (d, J = 8.0 Hz, 2H, Ph-H), 7.47 (d, J = 8.0 Hz, 2H, Ph-H), 6.35 (d, J = 4.8 Hz, 1H, pyrimidine-H), 5.28
(s, 2H, CH2), 3.87 (bs, 4H, piperazine-H), 2.89 (bs, 4H, piperazine-H), 2.31 (s, 3H, CH3)
11.21 (s, 1H, CH), 7.70-8.18 (m, 5H, Ph-H þ pyrimidine-H), 6.36 (d, J = 4.8 Hz, 1H, pyrimidine-H), 5.28 (s, 2H, CH2), 3.88 (bs, 4H, piperazine-H), 2.90 (bs, 4H,
piperazine-H), 2.31 (s, 3H, CH3)
6j
10.35 (s, 1H, CH), 7.47-7.88 (m, 5H, Ph-H), 6.25 (s, 1H, pyrimidine-H), 5.29 (s, 2H, CH2), 3.89 (t, J = 4.4 Hz, 4H, piperazine-H), 2.89 (t, J = 4.4 Hz, 4H, piperazine-H),
2.26 (s, 6H, CH3)
6k
6l
10.70 (s, 1H, CH), 7.15-8.09 (m, 4H, Ph-H), 6.25 (s, 1H, pyrimidine-H), 5.29 (s, 2H, CH2), 3.88 (t, J = 4.0 Hz, 4H, piperazine-H), 2.89 (t, J = 4.0 Hz, 4H, piperazine-H),
2.26 (s, 6H, CH3)
10.08 (s, 1H, CH), 7.83 (d, J = 8.0 Hz, 2H, Ph-H), 6.99 (d, J = 8.0 Hz, 2H, Ph-H), 6.25 (s, 1H, pyrimidine-H), 5.29 (s, 2H, CH2), 3.89 (bs, 7H, CH3O þ piperazine-H),
2.88 (bs, 4H, piperazine-H), 2.26 (s, 6H, CH3)
6m
6n
10.11 (s, 1H, CH), 7.63 (s, 1H, Ph-H), 7.60 (d, J = 8.0 Hz, 1H, Ph-H), 7.25 (d, J = 8.0 Hz, 1H, Ph-H), 6.25 (s, 1H, pyrimidine-H), 5.28 (s, 2H, CH2), 3.88 (t, J = 4.4 Hz, 4H,
piperazine-H), 2.88 (t, J = 4.4 Hz, 4H, piperazine-H), 2.34 (s, 3H, Ph-CH3), 2.33 (s, 3H, Ph-CH3), 2.26 (s, 6H, pyrimidine-CH3)
10.44 (s, 1H, CH), 7.80 (d, J = 8.0 Hz, 2H, Ph-H), 7.47 (d, J = 8.0 Hz, 2H, Ph-H), 6.25 (s, 1H, pyrimidine-H), 5.28 (s, 2H, CH2), 3.88 (bs, 4H, piperazine-H), 2.88 (bs, 4H,
piperazine-H), 2.26 (s, 6H, CH3)
6o
7a
7b
7c
7d
11.21 (s, 1H, CH), 7.70-8.18 (m, 4H, Ph-H), 6.25 (s, 1H, pyrimidine-H), 5.29 (s, 2H, CH2), 3.89 (bs, 4H, piperazine-H), 2.89 (bs, 4H, piperazine-H), 2.26 (s, 6H, CH3)
10.35 (s, 2H, CH), 7.48-7.59 (m, 10H, Ph-H), 5.19 (s, 4H, CH2), 2.88 (s, 8H, piperazine-H)
10.71 (s, 2H, CH), 7.15-8.10 (m, 8H, Ph-H), 5.18 (s, 4H, CH2), 2.88 (s, 8H, piperazine-H)
10.08 (s, 2H, CH), 7.83 (d, J = 8.8 Hz, 4H, Ph-H), 6.99 (d, J = 8.8 Hz, 4H, Ph-H), 5.18 (s, 4H, CH2), 3.89 (s, 6H, OCH3), 2.87 (s, 8H, piperazine-H)
10.12 (s, 2H, CH), 7.24-7.64 (m, 6H, Ph-H), 5.18 (s, 4H, CH2), 2.88 (s, 8H, piperazine-H), 2.34 (s, 6H, CH3), 2.33 (s, 6H, CH3)
6-A1 10.11 (s, 1H, CH), 8.28 (d, J = 4.8 Hz, 2H, pyrimidine-H), 7.63 (s, 1H, Ph-H), 7.60 (d, J = 8.0 Hz, 1H, Ph-H), 7.24 (d, J = 8.0 Hz, 1H, Ph-H), 6.47 (t, J = 4.8 Hz, 1H,
pyrimidine-H), 5.28 (s, 2H, CH2), 3.87 (t, J = 4.8 Hz, 4H, piperazine-H), 2.90 (t, J = 4.8 Hz, 4H, piperazine-H), 2.33 (s, 3H, CH3), 2.32 (s, 3H, CH3)
6-A2 10.44 (s, 1H, CH), 8.28 (d, J = 4.8 Hz, 2H, pyrimidine-H), 7.80 (d, J = 8.8 Hz, 2H, Ph-H), 7.46 (d, J = 8.8 Hz, 2H, Ph-H), 6.47 (t, J = 4.8 Hz, 1H, pyrimidine-H), 5.28
(s, 2H, CH2), 3.87 (t, J = 4.4 Hz, 4H, piperazine-H), 2.90 (t, J = 4.4 Hz, 4H, piperazine-H)
6-A3 11.22 (s, 1H, CH), 8.29 (d, J = 4.8 Hz, 2H, pyrimidine-H), 7.70-8.19 (m, 4H, Ph-H), 6.47 (t, J = 4.8 Hz, 1H, pyrimidine-H), 5.28 (s, 2H, CH2), 3.87 (t, J = 4.4 Hz, 4H,
piperazine-H), 2.91 (t, J = 4.4 Hz, 4H, piperazine-H)
7-A1 10.45 (s, 2H, CH), 7.81 (d, J = 8.4 Hz, 4H, Ph-H), 7.47 (d, J = 8.4 Hz, 4H, Ph-H), 5.17 (s, 4H, CH2), 2.87 (s, 8H, piperazine-H)
7-A2 11.21 (s, 2H, CH), 7.71-8.19 (m, 8H, Ph-H), 5.18 (s, 4H, CH2), 2.89 (s, 8H, piperazine-H)
(goodness of fit) was judged by the correlation coefficient squared, r2,
and the prediction capability (goodness of prediction) was indicated by
the cross-validated r2 (q2).
Table 3. IR Spectral Data of Compounds 6 and 7
ν (cm-1) (KBr)
compound
6a
2860, 2825 (C-H), 1587 (CdN), 1550, 1506, 1483, 1465 (Ar),
1310, 1205 (C-F), 1161 (CdS)
RESULTS AND DISCUSSION
6d
6j
2980, 2830 (C-H), 1578 (CdN), 1566, 1489, 1467, 1449 (Ar),
1316, 1194 (C-F), 1161 (CdS)
2941, 2853 (C-H), 1577 (CdN), 1504, 1467, 1449 (Ar), 1311,
1194 (C-F), 1156 (CdS)
2935, 2822 (C-H), 1599 (CdN), 1583, 1463, 1452 (Ar), 1317,
1193 (C-F), 1156 (CdS)
Synthesis. The synthesis procedures for compounds 6 were
shown in Scheme 1, and the synthesis procedures for compounds
7 were shown in Scheme 2. According to the method described in
ref22 for the synthesis of required 4-(4,6-disubstituted-pyrimidin-
2-yl)piperazine 2, a small amount of 1,4-bis(4,6-disubstituted-
pyrimidin-2-yl) piperazine 3 was also obtained, which was not
mentioned in the literature. Compound 3 was further confirmed
by 1H NMR spectra. In reference to an acetic acid solvent method
reported by Wu et al. for the condensation of amine and
aldehyde (28), Schiff base 5, namely, 4-amino-5-trifluoromethyl-
4H-1,2,4-trizole-3-thiol, was prepared successfully. The Mannich
reaction of compound 5 with formaldehyde and pyrimidyl-
piperazine 2 in ethanol at room temperature led to novel tri-
fluoromethyl-substituted 1,2,4-triazole Mannich base 6. In a 2:1
molar ratio of Schiff base 5 and piperazine, novel trifluoromethyl-
substituted bis(1,2,4-triazole) Mannich base 7 was prepared
conveniently in 60-88% yield using the same procedures for
compound 6. Compounds 6 and 7 were identified by 1H NMR
and infrared (IR) spectra (Tables 2 and 3). The measured
7a
elemental analyses were also consistent with the corresponding
calculated ones (Table 1).
Crystal Structure. The structure of compound 6i was further
confirmed by single-crystal X-ray diffraction analysis (Figure 1).
From the molecular structure, it can be seen that both groups on
the N atoms of the piperazine ring (triazole-CH2 and pyrimidine)
are in the e-bond positions of chair conformation in the six-
membered ring. The dihedral angle between the 2-nitrobenzene
ring and the triazole ring is 32°, which indicates that the two rings
are not coplanar in the molecular structure. The X-ray analysis
also reveals that, in this typical compound 6i, the substi-
tuted benzene ring and the triazole ring are on the opposite
sides of the CdN double bond (Figure 1). The torsion angle of